{{header
 | author     = Michael C. Burgess
 | related_author = United States Congress
 | translator = 
 | section    = 
 | previous   = 
 | next       = 
 | year       = 2013
 | month      = 03
 | day        = 15
 | notes      = ''{{USBill|113|H.R.|1220}}'' as introduced
 | categories =
 | portal     =
 | congress   = 113
 | session    = 1
 | title      = Asthma Inhalers Relief Act of 2013 ( H.R. 1220; 113th Congress)
 | bill       = 1220
 | billtype   = hr
 | purpose    = To direct the Administrator of the Environmental Protection Agency to allow for the distribution, sale, and consumption in the United States of remaining inventories of over-the-counter CFC epinephrine inhalers.
 | wikipedia  =
}}
      
{{Center|113th CONGRESS}}

 
{{Center|1st Session}}

 
{{Center|H. R. 1220}}

 
{{Center|IN THE HOUSE OF REPRESENTATIVES}}

  
{{Center|March 15, 2013}}

 
{{Center| 
[[w:Michael C. Burgess|Mr. Burgess]](for himself,
[[w:John Dingell|Mr. Dingell]], and
[[w:Jim Matheson|Mr. Matheson]]) introduced the following bill; which was referred to the [[w:United States House Committee on Energy and Commerce|Committee on Energy and Commerce]] }}

  
{{Center|A BILL}}

 To direct the Administrator of the Environmental Protection Agency to allow for the distribution, sale, and consumption in the United States of remaining inventories of over-the-counter CFC epinephrine inhalers.   

=Section 1. Short title=

This Act may be cited as the“ Asthma Inhalers Relief Act of 2013 ”. 

=Sec. 2. Distribution, sale, and consumption of remaining inventories of over-the-counter CFC epinephrine inhalers=



==(a) In general– ==

The [[w:United States Environmental Protection Agency|Administrator of the Environmental Protection Agency]]—
:(1) shall allow for the distribution, sale, and consumption in the United States of remaining inventories of CFC epinephrine inhalers manufactured pursuant to the exception for medical devices under  section 604(d)(2) of the Clean Air Act ( [http://www.law.cornell.edu/uscode/text/42/7671c 42 U.S.C. 7671c(d)(2)] );
:(2) shall not take any enforcement action or otherwise seek to restrict the distribution, sale, or consumption of such inhalers on the basis of any Federal law implementing the Montreal Protocol; and
:(3) shall, in response to any request of any distributor or seller of such inhalers, including any such request pending on the date of the enactment of this Act, issue a No Action Assurance Letter to the requesting party stating that the [[w:United States Environmental Protection Agency|Environmental Protection Agency]]will not initiate an enforcement action relating to the distribution or sale of any such inhaler occurring prior to August 1, 2013.

==(b) Rule of construction– ==

Nothing in this Act shall be construed to limit or otherwise affect the authority of the [[w:Food and Drug Administration|Food and Drug Administration]]under the  Federal Food, Drug, and Cosmetic Act ([http://www.law.cornell.edu/uscode/text/21/301 21 U.S.C. 301 et seq.])to ensure the safety and effectiveness of CFC epinephrine inhalers to be distributed, sold, or consumed pursuant to this Act.

==(c) Definitions– ==

In this Act:
:(1) The term CFC epinephrine inhaler means any epinephrine inhaler containing chlo­ro­fluo­ro­car­bons that was manufactured and classified as over-the-counter before January 1, 2012.
:(2) The phrase Federal law implementing the Montreal Protocol —
::(A) means any provision of  title VI of the Clean Air Act ([http://www.law.cornell.edu/uscode/text/42/7671 42 U.S.C. 7671 et seq.])or other Federal law implementing the Montreal Protocol; and
::(B) includes the final rule published by the [[w:Food and Drug Administration|Food and Drug Administration]]entitled Use of Ozone-Depleting Substances; Removal of Essential-Use Designation (Epinephrine) published in the Federal Register at 73 Federal Register 69532 (November 19, 2008).
:(3) The term Montreal Protocol has the meaning given such term in  section 601 of the Clean Air Act ([http://www.law.cornell.edu/uscode/text/42/7671 42 U.S.C. 7671]).
:(4) The term over-the-counter means not subject to  section 503(b)(1) of the Federal Food, Drug, and Cosmetic Act ( [http://www.law.cornell.edu/uscode/text/21/353 21 U.S.C. 353(b)(1)] )or otherwise required pursuant to Federal law to be dispensed only upon issuance of a prescription.

==(d) Sunset– ==

This section ceases to be effective August 1, 2013.  
{{PD-USGov}}
[[Category:Proposed United States federal law]]
[[Category:Proposed United States federal law of the 113th Congress]]
